Literature DB >> 3007320

Immunohistochemical demonstration of p24 HTLV III major core protein in different cell types within lymph nodes from patients with lymphadenopathy syndrome (LAS).

C D Baroni, F Pezzella, M Mirolo, L P Ruco, G B Rossi.   

Abstract

The p24 protein is the major core protein of LAV/HTLV III which is the putative agent of the lymphadenopathy syndrome. By the use of an anti-p24 monoclonal antibody we have studied the presence of LAV/HTLV III infected cells in 20 lymph nodes obtained from lymphadenopathy syndrome patients: 14 lymph nodes were characterized by prominent follicular hyperplasia consistent with the early phase of the syndrome and six lymph nodes presented marked regressive changes. Cells positive for p24 were detected in 8/14 lymph nodes with hyperplastic changes and in 1/6 lymph nodes with regressive changes. Positive cells were most often located in germinal centres and were mainly characterized by a lymphoid morphology. However, immunoreactivity for p24 protein was also occasionally observed in some histiocytic-like cells and in high endothelial cells of post-capillary venules, suggesting that these 'accessory cells' also play a role in the early phases of the lymphadenopathy syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007320     DOI: 10.1111/j.1365-2559.1986.tb02456.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  11 in total

1.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.

Authors:  D Emilie; M Peuchmaur; M C Maillot; M C Crevon; N Brousse; J F Delfraissy; J Dormont; P Galanaud
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

2.  Expression of HIV in lymph node cells of LAS patients. Immunohistology, in situ hybridization, and identification of target cells.

Authors:  C D Baroni; F Pezzella; M Pezzella; B Macchi; D Vitolo; S Uccini; L P Ruco
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals.

Authors:  H J Schuurman; W J Krone; R Broekhuizen; J Goudsmit
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

4.  Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy.

Authors:  D J Ringler; M S Wyand; D G Walsh; J J MacKey; L V Chalifoux; M Popovic; A A Minassian; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 5.  Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.

Authors:  O J Cohen; G Pantaleo; G K Lam; A S Fauci
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.

Authors:  O J Cohen; G Pantaleo; M Holodniy; S Schnittman; M Niu; C Graziosi; G N Pavlakis; J Lalezari; J A Bartlett; R T Steigbigel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

7.  CD4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells.

Authors:  O Scheglovitova; M R Capobianchi; G Antonelli; D Guanmu; F Dianzani
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections.

Authors:  J M Ward; T J O'Leary; G B Baskin; R Benveniste; C A Harris; P L Nara; R H Rhodes
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

9.  Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution.

Authors:  J Embretson; M Zupancic; J Beneke; M Till; S Wolinsky; J L Ribas; A Burke; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

10.  Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients.

Authors:  K Tenner-Racz; P Racz; C Thomé; C G Meyer; P J Anderson; S F Schlossman; N L Letvin
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.